We found poorer overall survival for high vs. low FOXA1 gene expression amongst patients with any breast cancer subtype (n = 2976) as well as with HR+ breast cancer (n = 2005) specifically (Figure 4a,b). Here, FOXA1 is linked to breast carcinoma.